Cargando…

Projected Estimates of Opioid Mortality After Community-Level Interventions

IMPORTANCE: The United States is experiencing a crisis of opioid overdose. In response, the US Department of Health and Human Services has defined a goal to reduce overdose mortality by 40% by 2022. OBJECTIVE: To identify specific combinations of 3 interventions (initiating more people to medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linas, Benjamin P., Savinkina, Alexandra, Madushani, R. W. M. A., Wang, Jianing, Eftekhari Yazdi, Golnaz, Chatterjee, Avik, Walley, Alexander Y., Morgan, Jake R., Epstein, Rachel L., Assoumou, Sabrina A., Murphy, Sean M., Schackman, Bruce R., Chrysanthopoulou, Stavroula A., White, Laura F., Barocas, Joshua A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885041/ https://www.ncbi.nlm.nih.gov/pubmed/33587136 http://dx.doi.org/10.1001/jamanetworkopen.2020.37259

Ejemplares similares

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
por: Morgan, Jake R., et al.
Publicado: (2020)

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
por: Chatterjee, Avik, et al.
Publicado: (2023)

302. HCV Care in Federally Qualified Health Centers During the Opioid Epidemic: A Retrospective Cohort Study
por: Assoumou, Sabrina A, et al.
Publicado: (2019)

Hepatitis C Testing Strategies in a Correctional Setting
por: Assoumou, Sabrina A, et al.
Publicado: (2017)

Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study
por: Barocas, Joshua A, et al.
Publicado: (2022)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021)

2570. HCV Screening Practices Among Adolescents and Young Adults in a National Sample of Federally Qualified Health Centers in the United States
por: Epstein, Rachel L, et al.
Publicado: (2018)

The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes
por: Linas, Benjamin P., et al.
Publicado: (2014)

HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
por: Morgan, Jake R., et al.
Publicado: (2021)

Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics
por: Jawa, Raagini, et al.
Publicado: (2023)

2494. Massachusetts HCV Treatment Report Card: Hepatitis C Virus Care Cascade for Women of Reproductive Age with Opioid Use Disorder, 2014-2020
por: Epstein, Rachel L, et al.
Publicado: (2023)

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose
por: Linas, Benjamin P., et al.
Publicado: (2021)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis
por: Adams, Joëlla W., et al.
Publicado: (2022)

Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study
por: Aldridge, Arnie P., et al.
Publicado: (2020)

Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island
por: Zang, Xiao, et al.
Publicado: (2022)

58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis
por: Adams, Joella W, et al.
Publicado: (2021)

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
por: Akiyama, Matthew J., et al.
Publicado: (2018)

Predictors and impact of survivorship care plans and survivorship care visits
por: Saiganesh, Harish, et al.
Publicado: (2023)

Relationship Between Hepatitis C Clinical Testing Site and Linkage to Care
por: Assoumou, Sabrina A., et al.
Publicado: (2014)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis
por: Kimmel, Simeon D., et al.
Publicado: (2020)

Implementation and reporting of causal mediation analysis in 2015: a systematic review in epidemiological studies
por: Liu, Shao-Hsien, et al.
Publicado: (2016)

Opioid use disorder treatment for people experiencing homelessness: A scoping review
por: McLaughlin, Matthew F., et al.
Publicado: (2021)

Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19
por: Ledesma, Jorge R., et al.
Publicado: (2022)

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
por: Martin, Anna K., et al.
Publicado: (2023)

Laboratory test trends within 72 hours of hospital admission associated with death among COVID-19 patients
por: Zambrano, Sarah, et al.
Publicado: (2022)

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs
por: Barocas, Joshua A., et al.
Publicado: (2016)

Economic evaluation of HCV testing approaches in low and middle income countries
por: Morgan, Jake R., et al.
Publicado: (2017)

Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
por: Nolen, Shayla, et al.
Publicado: (2023)

Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
por: Nolen, Shayla, et al.
Publicado: (2023)

Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment
por: McNeely, Jennifer, et al.
Publicado: (2019)

333. Comparing COVID-19-related Morbidity and Mortality between Patients with and without Substance Use Disorder: A Retrospective Cohort Study
por: McLaughlin, Angela, et al.
Publicado: (2021)

A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study
por: Kapadia, Shashi N., et al.
Publicado: (2021)

Closing the gaps in opioid use disorder research, policy and practice: conference proceedings
por: Miclette, Matthew A., et al.
Publicado: (2018)

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets
por: Morgan, Jake R, et al.
Publicado: (2017)

Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids
por: Jawa, Raagini, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d9df6pvs2b2aj6ciavr51ap862